213 related articles for article (PubMed ID: 21318564)
1. A pilot study of the effectiveness of D-cycloserine during cue-exposure therapy in abstinent alcohol-dependent subjects.
Watson BJ; Wilson S; Griffin L; Kalk NJ; Taylor LG; Munafò MR; Lingford-Hughes AR; Nutt DJ
Psychopharmacology (Berl); 2011 Jul; 216(1):121-9. PubMed ID: 21318564
[TBL] [Abstract][Full Text] [Related]
2. Effects of D-cycloserine on extinction of mesolimbic cue reactivity in alcoholism: a randomized placebo-controlled trial.
Kiefer F; Kirsch M; Bach P; Hoffmann S; Reinhard I; Jorde A; von der Goltz C; Spanagel R; Mann K; Loeber S; Vollstädt-Klein S
Psychopharmacology (Berl); 2015 Jul; 232(13):2353-62. PubMed ID: 25697860
[TBL] [Abstract][Full Text] [Related]
3. D-cycloserine combined with cue exposure therapy fails to attenuate subjective and physiological craving in cocaine dependence.
Santa Ana EJ; Prisciandaro JJ; Saladin ME; McRae-Clark AL; Shaftman SR; Nietert PJ; Brady KT
Am J Addict; 2015 Apr; 24(3):217-224. PubMed ID: 25808169
[TBL] [Abstract][Full Text] [Related]
4. Changes in cue reactivity and attentional bias following experimental cue exposure and response prevention: a laboratory study of the effects of D-cycloserine in heavy drinkers.
Kamboj SK; Massey-Chase R; Rodney L; Das R; Almahdi B; Curran HV; Morgan CJ
Psychopharmacology (Berl); 2011 Sep; 217(1):25-37. PubMed ID: 21455709
[TBL] [Abstract][Full Text] [Related]
5. Cognitive enhancers as adjuncts to psychotherapy: use of D-cycloserine in phobic individuals to facilitate extinction of fear.
Ressler KJ; Rothbaum BO; Tannenbaum L; Anderson P; Graap K; Zimand E; Hodges L; Davis M
Arch Gen Psychiatry; 2004 Nov; 61(11):1136-44. PubMed ID: 15520361
[TBL] [Abstract][Full Text] [Related]
6. D-Cycloserine attenuates reactivity to smoking cues in nicotine dependent smokers: a pilot investigation.
Santa Ana EJ; Rounsaville BJ; Frankforter TL; Nich C; Babuscio T; Poling J; Gonsai K; Hill KP; Carroll KM
Drug Alcohol Depend; 2009 Oct; 104(3):220-7. PubMed ID: 19592176
[TBL] [Abstract][Full Text] [Related]
7. D-cycloserine and cocaine cue reactivity: preliminary findings.
Price KL; McRae-Clark AL; Saladin ME; Maria MM; DeSantis SM; Back SE; Brady KT
Am J Drug Alcohol Abuse; 2009; 35(6):434-8. PubMed ID: 20014913
[TBL] [Abstract][Full Text] [Related]
8. A randomized, placebo-controlled laboratory study of the effects of D-cycloserine on craving in cocaine-dependent individuals.
Price KL; Baker NL; McRae-Clark AL; Saladin ME; Desantis SM; Santa Ana EJ; Brady KT
Psychopharmacology (Berl); 2013 Apr; 226(4):739-46. PubMed ID: 22234379
[TBL] [Abstract][Full Text] [Related]
9. D-cycloserine to enhance extinction of cue-elicited craving for alcohol: a translational approach.
MacKillop J; Few LR; Stojek MK; Murphy CM; Malutinok SF; Johnson FT; Hofmann SG; McGeary JE; Swift RM; Monti PM
Transl Psychiatry; 2015 Apr; 5(4):e544. PubMed ID: 25849983
[TBL] [Abstract][Full Text] [Related]
10. Effects of D-cycloserine on craving to alcohol cues in problem drinkers: preliminary findings.
Hofmann SG; Hüweler R; MacKillop J; Kantak KM
Am J Drug Alcohol Abuse; 2012 Jan; 38(1):101-7. PubMed ID: 21851195
[TBL] [Abstract][Full Text] [Related]
11. A placebo-controlled randomized trial of D-cycloserine augmentation of cue exposure therapy for smoking cessation.
Otto MW; Pachas GN; Cather C; Hoeppner SS; Moshier SJ; Hearon BA; Ward HB; Laffer AB; Smits JAJ; Evins AE
Cogn Behav Ther; 2019 Jan; 48(1):65-76. PubMed ID: 30111253
[TBL] [Abstract][Full Text] [Related]
12. Cue exposure and response prevention with heavy smokers: a laboratory-based randomised placebo-controlled trial examining the effects of D-cycloserine on cue reactivity and attentional bias.
Kamboj SK; Joye A; Das RK; Gibson AJ; Morgan CJ; Curran HV
Psychopharmacology (Berl); 2012 May; 221(2):273-84. PubMed ID: 22101394
[TBL] [Abstract][Full Text] [Related]
13. D-cycloserine effects on extinction of conditioned responses to drug-related cues.
Myers KM; Carlezon WA
Biol Psychiatry; 2012 Jun; 71(11):947-55. PubMed ID: 22579305
[TBL] [Abstract][Full Text] [Related]
14. Combining D-cycloserine with appetitive extinction learning modulates amygdala activity during recall.
Ebrahimi C; Koch SP; Friedel E; Crespo I; Fydrich T; Ströhle A; Heinz A; Schlagenhauf F
Neurobiol Learn Mem; 2017 Jul; 142(Pt B):209-217. PubMed ID: 28512009
[TBL] [Abstract][Full Text] [Related]
15. Effects of D-cycloserine on cue-induced craving and cigarette smoking among concurrent cocaine- and nicotine-dependent volunteers.
Yoon JH; Newton TF; Haile CN; Bordnick PS; Fintzy RE; Culbertson C; Mahoney JJ; Hawkins RY; LaBounty KR; Ross EL; Aziziyeh AI; La Garza R
Addict Behav; 2013 Feb; 38(2):1518-1526. PubMed ID: 22560371
[TBL] [Abstract][Full Text] [Related]
16. Cognitive-behavioural therapy with post-session D-cycloserine augmentation for paediatric obsessive-compulsive disorder: pilot randomised controlled trial.
Mataix-Cols D; Turner C; Monzani B; Isomura K; Murphy C; Krebs G; Heyman I
Br J Psychiatry; 2014 Jan; 204(1):77-8. PubMed ID: 24262813
[TBL] [Abstract][Full Text] [Related]
17. Modeling cue-exposure therapy for alcohol use disorder in rhesus monkeys: Effects of putative cognitive enhancers.
Pareek T; Overton JS; Nguyen LT; Rahman MT; Sharmin D; Cook JM; Platt DM
Drug Alcohol Depend; 2023 Feb; 243():109735. PubMed ID: 36549228
[TBL] [Abstract][Full Text] [Related]
18. A meta-analysis of D-cycloserine and the facilitation of fear extinction and exposure therapy.
Norberg MM; Krystal JH; Tolin DF
Biol Psychiatry; 2008 Jun; 63(12):1118-26. PubMed ID: 18313643
[TBL] [Abstract][Full Text] [Related]
19. Learn to forget: Does post-exposure administration of d-cycloserine enhance fear extinction in agoraphobia?
Pyrkosch L; Mumm J; Alt I; Fehm L; Fydrich T; Plag J; Ströhle A
J Psychiatr Res; 2018 Oct; 105():153-163. PubMed ID: 30237105
[TBL] [Abstract][Full Text] [Related]
20. D-cycloserine augmentation of exposure therapy for post-traumatic stress disorder: a pilot randomized clinical trial.
Difede J; Cukor J; Wyka K; Olden M; Hoffman H; Lee FS; Altemus M
Neuropsychopharmacology; 2014 Apr; 39(5):1052-8. PubMed ID: 24217129
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
